	A noninvasive urinary microRNA-based assay for early detection of lung cancer and its potential application to prognosis and recurrence monitoring: a case-control study. NPJ Precis Oncol Kiritani A, Mori S, Nojiri T, Watanabe J, Yamaguchi H, Ando Y, Nishiyama Y, Mizunuma M, Ichikawa Y, Kato Y, Araya J, Ohtsuka T, Higashiyama M, Fujita Y. PMID: 42000891 [PubMed - as supplied by publisher]
	Causal inference of glucocorticoid signaling in non-small cell lung cancer: integrating Mendelian randomization, single-cell transcriptomics, and imaging data. NPJ Precis Oncol Hong T, Su L, Xue W, Dai Y, Zhang B, Huang B, Yang W, Wang H. PMID: 42000855 [PubMed - as supplied by publisher]
	Exploring the characteristics of gut microbiome changes in lung cancer patients and healthy controls. Sci Rep Xu P, Chen J, Lu X, Luo H. PMID: 42000796 [PubMed - as supplied by publisher]
	Second primary malignancies after stereotactic body radiotherapy vs surgery for early-stage lung cancer: a U.S. population-based study, 2010-2015. Cancer Treat Res Commun Ni L, Zhang Z, Liu Z, Liu X. PMID: 42000698 [PubMed - as supplied by publisher]
	Node-RADS v1.0 on chest CT for lung cancer: Reproducibility and diagnostic performance. Eur J Radiol Cereser L, Nadarevi, Ciancimino C, Versienti E, Pace AP, Como G, De Pellegrin A, Cortiula F, Aprile G, Zuiani C, Girometti R. PMID: 42000469 [PubMed - as supplied by publisher]
	Five-year overall survival in JCOG1205/1206: irinotecan or etoposide plus cisplatin for resected high-grade neuroendocrine carcinoma of the lung. Lung Cancer Kenmotsu H, Niho S, Tsuboi M, Wakabayashi M, Ishii G, Asahina H, Watanabe K, Kiyoshima M, Iwata T, Nakamura Y, Nakahara Y, Chen-Yoshikawa TF, Nishino K, Nishio W, Yokoyama T, Mitome N, Asamura H, Ohe Y, Watanabe SI. PMID: 42000139 [PubMed - as supplied by publisher]
	Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 study. Cancer Cell Planchard D, Cozic N, Mosele MF, Corcos N, Le Bescond L, Pradat Y, Ghigna MR, Nachabeh G, Alfaro A, Catelain C, Job B, Mami-Chouaib F, Badel S, Corgnac S, Farace F, Oulhen M, Kannouche P, Ngoc Tran DT, Droin N, Wislez M, Chouaid C, Curcio H, Cousin S, Mascaux C, Cadranel J, Geier M, Cheikh-Hussin R, Guyader P, Signolle N, Godefroy K, Talbot H, Vakalopoulou M, Christodoulidis S, Bernard E, Koudou Y, Camara V, Belarkemi A, Klein A, Morretton JP, East P, Chiaverelli R, Zwirtes R, Michiels S, Barlesi F, André F, Montagnac G, Pistilli B. PMID: 41999747 [PubMed - as supplied by publisher]
	Trends in cause of death among patients with non-small cell lung cancer in the United States from 2000 to 2021: a SEER-based study. BMC Public Health Wang X, Sun C, Lu Y, He B, Zhao T, Liu Y, Su X. PMID: 41998605 [PubMed - as supplied by publisher]
	Programmed cell death in lung cancer: mechanisms, immune responses, and therapeutics. Apoptosis Liu Y, Chen Q, Xu J, Chi H. PMID: 41998294 [PubMed - indexed for MEDLINE]
	Clustering by patients-related characteristics identifies specific phenotypes with different prognosis after resection of non-small cell lung cancer: a French nationwide study from the Epithor database. Thorax Gherzi L, Daffré E, Prieto M, Thomas PA, Le Pimpec-Barthes F, Falcoz PE, Brouchet L, Dahan M, Alifano M. PMID: 41997853 [PubMed - as supplied by publisher]
	Sex-based differences in effectiveness of immune checkpoint inhibitors in the treatment of advanced non-small-cell lung cancer: systematic review and meta-analysis. Thorax Suazo-Zepeda E, Talen GG, van der Werf S, Hiltermann JTJN, Maas W, De Bock GH, Heuvelmans MA. PMID: 41997852 [PubMed - as supplied by publisher]
	Stereotactic Versus Conventional Radiotherapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer: A Bayesian Reanalysis of the LUSTRE Randomized Trial. Clin Lung Cancer Wang Y, Donovan EK, Levine MN, Whelan TJ, Swaminath A, Parpia S, LUSTRE Trial Investigators. PMID: 41997828 [PubMed - as supplied by publisher]
	Mapping the Immune Microenvironment of Non-small Cell Lung Cancer. Crit Rev Oncol Hematol Ge X, Cai M, Nie J, Wang L, Li Y, Hu Y, Meng J, Liu H, Geng L, Hua B, Liu R. PMID: 41997512 [PubMed - as supplied by publisher]
	Disease characteristics and treatment outcomes in patients with resected early-stage ALK-positive non-small cell lung cancer from the randomized ALINA trial. Lung Cancer Barlesi F, Ahn JS, Solomon BJ, Nishio M, Dziadziuszko R, Lee DH, Lee JS, Zhong W, Horinouchi H, Mao W, Hochmair M, de Marinis F, Migliorino MR, Bondarenko I, Xu T, Bara I, Ding B, Ngiam C, Petric P, Wu YL. PMID: 41996761 [PubMed - as supplied by publisher]
	Dissecting the prognostic role of metabolic markers in lung neuroendocrine Tumors: The MONET study. Lung Cancer Pasello G, Pigato G, Mulargiu C, Ferrarini F, Pezzuto F, Schiavon M, Ferro A, Scattolin D, Maso AD, Frega S, Bonanno L, Calabrese F, Dell'Amore A, Guarneri V, Indraccolo S. PMID: 41996760 [PubMed - as supplied by publisher]
	Caplan syndrome presenting as tumour-like pulmonary nodules in a patient with rheumatoid arthritis: a diagnostic challenge. Scand J Rheumatol Zhang Z, Kang L, Zhang Z. PMID: 41995015 [PubMed - as supplied by publisher]
	Delayed Diagnosis of Primary Bronchial Adenoid Cystic Carcinoma Presenting as Central Airway Obstruction: A Case Report. Cureus Fikri O, Lhachimi K, Rachid C, Ijim M, Amro L. PMID: 41994769 [PubMed]
	Efficacy of first-line immune checkpoint inhibitors in advanced non-small-cell lung cancer with or without brain metastases: a systematic review and network meta-analysis. Front Oncol Luo J, Han M, Sima M, Cui Y, Yu Z, Dong C, Ma K, Yue D. PMID: 41994648 [PubMed]
	Non-small cell lung cancer research: advances and persistent challenges. Front Oncol Zhou L, Jiang J. PMID: 41994634 [PubMed]
	Global disparities in access to diagnostics and therapies for advanced non-small cell lung cancer: from discovery to delivery - a review. Front Oncol Ruge L, Verheyen M, John F, Wolf J. PMID: 41994633 [PubMed]

Articles 1 - 20 / 158939

Page 1 of 7947



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy